Brain damage in preterm newborns: biological response modification as a strategy to reduce disabilities (Q33884684)

29 July 2017

1 reference

title

Brain damage in preterm newborns: biological response modification as a strategy to reduce disabilities (English)

1 reference

29 July 2017

0 references

Dammann O

1

1 reference

29 July 2017

Leviton A

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

The Journal of Pediatrics

29 July 2017

published in

1 reference

29 July 2017

volume

136

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

433-438

1 reference

Outcome among surviving very low birthweight infants: a meta-analysis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Changing prognosis for babies of less than 28 weeks' gestation in the north of England between 1983 and 1994. Northern Neonatal Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

School attainment, cognitive ability and motor function in a total Scottish very-low-birthweight population at eight years: a controlled study

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Long-term behavioral sequelae of prematurity.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Results at age 8 years of early intervention for low-birth-weight premature infants. The Infant Health and Development Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Outcomes of children of extremely low birthweight and gestational age in the 1990's

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Psychiatric outcomes in low-birth-weight children at age 6 years: relation to neonatal cranial ultrasound abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Brain damage in preterm newborns: might enhancement of developmentally regulated endogenous protection open a door for prevention?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Serum interleukin-1 beta in neonatal sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Ureaplasma urealyticum infection of the placenta in pregnancies that ended prematurely

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Bacterial vaginosis and intraamniotic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Role of the fetus in perinatal infection and neonatal brain damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Immunohistochemical expression of tumor necrosis factor alpha in neonatal leukomalacia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Characteristic neuropathology of leukomalacia in extremely low birth weight infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Intrauterine infection induces programmed cell death in rabbit periventricular white matter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Endotoxin leucoencephalopathy in the telencephalon of the newborn kitten

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Neonatal endotoxin encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Reperfusion injury as the mechanism of brain damage after perinatal asphyxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Cytokines and perinatal brain injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Excitotoxins in neuronal apoptosis and necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Mechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin-like growth factor-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Cytokine response in cerebrospinal fluid after birth asphyxia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Endogenous interleukin-1 receptor antagonist is neuroprotective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Can inhibition of apoptosis rescue ischemic brain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

The induction of ICAM-1 in human cerebromicrovascular endothelial cells (HCEC) by ischemia-like conditions promotes enhanced neutrophil/HCEC adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

TNF alpha and IL-1beta mediate intercellular adhesion molecule-1 induction via microglia-astrocyte interaction in CNS radiation injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Expression of intercellular adhesion molecule 1 (ICAM-1) is reduced in permanent focal cerebral ischemic mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

P-selectin antibody reduces hemorrhage and infarct volume resulting from MCA occlusion in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Anti-P-selectin antibody attenuates rat brain ischemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Reduction of ischemic brain injury by anti-P-selectin monoclonal antibody after permanent middle cerebral artery occlusion in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

IL-10 reduces rat brain injury following focal stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Principles of biotherapy and its application to the treatment of disseminated renal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Multiple sclerosis: immune mechanism and update on current therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

The use of biologic response modifiers in human clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Infliximab for the treatment of fistulas in patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Cell adhesion molecules in neural plasticity and pathology: similar mechanisms, distinct organizations?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

Preterm birth and cerebral palsy: is tumor necrosis factor the missing link?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2990004-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(00)90004-0

1 reference

29 July 2017

1 reference